Abstract
Over the last 5 years, several authors have measured apparent affinities and maximal translocation rates of the different erythrocyte Na+ transport systems in essential hypertensive patients. These kinetic studies have clearly shown that no unique red cell Na+ transport defect characterizes the whole population of essential hypertensive patients. Conversely, several complex patterns of erythrocyte Na+ transport abnormalities may be present in different subsets of essential hypertensive patients. These kinetic studies are now providing a more profound biochemical insight into the molecular heterogeneity of primary hypertension. In particular, they may permit the diagnosis and specific treatment of different forms of primary hypertension in the next decade.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
